JYJian Yang

Jian Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jian Yang has a total of 261 co-authors. Here are the top co-authors by number of shared publications:

  • Lihong Chen

    NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 102629

    23 shared publications
  • Qi Jin

    NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College

    19 shared publications
  • Bo Liu

    NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 102629

    15 shared publications
  • Lilian Sun

    Institute of Pathogen Biology

    12 shared publications
  • Qi Jin

    State Key Laboratory for Molecular Virology and Genetic Engineering

    12 shared publications
  • Jie Dong

    Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College

    10 shared publications

Latest Publications

  • Open Access

    PLM-effector: unleashing the potential of protein language models for bacterial secreted protein prediction

    by Dandan Zheng, Lihong Chen, Guansong Pang, Jian Yang

    Bacterial secreted proteins, particularly effectors delivered by specialized secretion systems, are key mediators of virulence and host–pathogen interactions. However, accurate computational identification remains challenging, as many existing methods rely heavily on sequence similarity or handcrafted features, and often focus on a single secretion system. Recent studies have reported that some bacterial effectors may be associated with more than one secretion system, highlighting the complexity of secretion system annotation and motivating the development of system-aware computational prediction approaches. Here, we present PLM-Effector, a hybrid deep learning framework that integrates modern protein language models (PLMs) with multiple neural architectures via a two-layer ensemble stacking strategy. By extracting complementary features from N- and C-terminal regions, PLM-Effector enables secretion-type-aware prediction across five major bacterial secretion systems (T1SS–T4SS and T6SS), with each system modeled independently. Systematic benchmarking shows that embeddings from protein-specific PLMs (ESM-1b, ESM2_t33, ProtT5) are more discriminative than those from general-purpose language models (e.g. BERT, BioBERT). Leveraging these representations, PLM-Effector achieves superior performance on an independent test set, with macro F1-scores of 0.9848, 0.8649, 0.9899, 0.9620, and 0.9728 for secreted proteins of T1SS–T4SS and T6SS, respectively, outperforming existing tools and homology-based baselines. Implemented as an accessible web server (http://www.mgc.ac.cn/PLM-Effector/) with source code and datasets available (https://github.com/zhengdd0422/PLM-Effector/), PLM-Effector provides a reproducible and user-friendly platform for both small-scale and genome-wide secreted protein discovery, facilitating advances in the study of bacterial pathogenesis.

  • Open Access

    ZOVER 2.0: a virome-based platform for zoonotic and vector-borne viruses

    by Bo Liu, Lin Zhu, Siyu Zhou, Aiyun Li, Panpan Xu, Yelin Han, Yuelong Shu, Lihong Chen, Jian Yang, Zhiqiang Wu

    Emerging zoonotic and vector-borne viruses pose a continuous threat to global public health, highlighting the need for effective virome surveillance that targets key wildlife reservoirs and vectors. Addressing this challenge requires a systematic understanding of both viral and host diversity, especially across broad spatiotemporal scales. Building on the previous genome-centric release, the upgraded ZOVER 2.0 (https://www.mgc.ac.cn/ZOVER/) expands its scope by incorporating 5883 curated metagenomic next-generation sequencing libraries from 72 independent projects, spanning 12 years and covering 362 distinct wildlife species of bats, rodents, mosquitoes, and ticks. To ensure consistent and sensitive virome profiling across heterogeneous datasets, ZOVER 2.0 employs a standardized analysis pipeline based on reads for taxonomic annotation and viral abundance estimation. After normalization, sequencing reads were collectively assigned to 110 recognized viral families, substantially expanding the known virome diversity within these four wildlife groups. Furthermore, a series of interactive modules enables users to visualize virome composition and perform comparative analyses across different host taxa, geographic regions, and temporal scales. By integrating current genomic and metagenomic knowledge, ZOVER 2.0 provides a robust platform for virus discovery, ecological interpretation, and surveillance of potential interspecies transmission, thereby contributing to One Health-oriented monitoring of emerging infectious diseases.


  • Open Access

    Heterologous expression of the M. abscessus CBASS system confers phage TM4 resistance in M. smegmatis

    by Chun-Liang Wang, Ao-Fei Duan, Da-Min Pan, Yi-Ou Zhao, Jian Yang, Yi-Cheng Sun

    Phage therapy for multidrug-resistant Mycobacterium abscessus is constrained by the narrow lytic spectrum of phages due to unknown antiphage mechanisms. Bacteria deploy various defense strategies to prevent phage infection, but few have been comprehensively characterized in mycobacteria. Mycobacteriophage TM4 successfully delivers DNA into M. abscessus but fails to establish infection. Bioinformatic analyses predicted three candidate phage defense systems and multiple individual putative defense proteins in M. abscessus. Among them, Mab_2091, Mab_2092, and Mab_2093, designated CmaABC, are components of a cyclic oligonucleotide-based antiphage signaling system (CBASS) preventing TM4 infection. However, the inability of TM4 to form plaques even in CBASS-deficient M. abscessus implies the involvement of additional resistance mechanisms. Our findings underscore the challenges faced by mycobacteriophages in infecting M. abscessus, and highlight the complex interactions between this pathogen and its viral adversaries.

  • Top Cited Papers
    Open Access

    VFDB 2025: an integrated resource for exploring anti-virulence compounds

    by Siyu Zhou, Bo Liu, Dandan Zheng, Lihong Chen, Jian Yang

    With the escalating crisis of bacterial multidrug resistance, anti-virulence therapeutic strategies have emerged as a highly promising alternative to conventional antibiotic treatments. Anti-virulence compounds are specifically designed to target virulence factors (VFs), disarming pathogens without affecting bacterial growth and thus reduce the selective pressure for resistance development. However, due to the complexity of bacterial pathogenesis, no anti-virulence small molecules have been approved for clinical use thus far, despite the documentation of hundreds of potential candidates. To provide valuable reference resources for drug design, repurposing, and target selection, the virulence factor database (VFDB, http://www.mgc.ac.cn/VFs/) has systematically collected public data on anti-virulence compounds through extensive literature mining, and further integrated this information with its existing knowledge of bacterial VFs. To date, the VFDB has curated a comprehensive dataset of 902 anti-virulence compounds across 17 superclasses reported by 262 studies worldwide. By cross-linking the current knowledge of bacterial VFs with information on relevant compounds (e.g. classification, chemical structure, molecular targets and mechanisms of action), the VFDB aims to bridge the gap between chemists and microbiologists, providing crucial insights for the development of innovative and effective antibacterial therapies to combat bacterial infections and address antibiotic resistance.


  • Open Access

    A deep learning method to predict bacterial ADP-ribosyltransferase toxins

    by Dandan Zheng, Siyu Zhou, Lihong Chen, Guansong Pang, Jian Yang

    ADP-ribosylation is a critical modification involved in regulating diverse cellular processes, including chromatin structure regulation, RNA transcription, and cell death. Bacterial ADP-ribosyltransferase toxins (bARTTs) serve as potent virulence factors that orchestrate the manipulation of host cell functions to facilitate bacterial pathogenesis. Despite their pivotal role, the bioinformatic identification of novel bARTTs poses a formidable challenge due to limited verified data and the inherent sequence diversity among bARTT members. We proposed a deep learning-based model, ARTNet, specifically engineered to predict bARTTs from bacterial genomes. Initially, we introduced an effective data augmentation method to address the issue of data scarcity in training ARTNet. Subsequently, we employed a data optimization strategy by utilizing ART-related domain subsequences instead of the primary full sequences, thereby significantly enhancing the performance of ARTNet. ARTNet achieved a Matthew’s correlation coefficient (MCC) of 0.9351 and an F1-score (macro) of 0.9666 on repeated independent test datasets, outperforming three other deep learning models and six traditional machine learning models in terms of time efficiency and accuracy. Furthermore, we empirically demonstrated the ability of ARTNet to predict novel bARTTs across domain superfamilies without sequence similarity. We anticipate that ARTNet will greatly facilitate the screening and identification of novel bARTTs from bacterial genomes. ARTNet is publicly accessible at http://www.mgc.ac.cn/ARTNet/. The source code of ARTNet is freely available at https://github.com/zhengdd0422/ARTNet/. Supplementary data are available at Bioinformatics online.


  • Open Access

    Genome wide analysis revealed conserved domains involved in the effector discrimination of bacterial type VI secretion system

    by Caihong Wang, Mingxing Chen, Yuhan Shao, Mengyuan Jiang, Quanjie Li, Lihong Chen, Yun Wu, Shan Cen, Nicholas R. Waterfield, Jian Yang, et al.

    Type VI secretion systems (T6SSs) deliver effectors into target cells. Besides structural and effector proteins, many other proteins, such as adaptors, co-effectors and accessory proteins, are involved in this process. MIX domains can assist in the delivery of T6SS effectors when encoded as a stand-alone gene or fused at the N-terminal of the effector. However, whether there are other conserved domains exhibiting similar encoding forms to MIX in T6SS remains obscure. Here, we scanned publicly available bacterial genomes and established a database which include 130,825 T6SS vgrG loci from 45,041 bacterial genomes. Based on this database, we revealed six domain families encoded within vgrG loci, which are either fused at the C-terminus of VgrG/N-terminus of T6SS toxin or encoded by an independent gene. Among them, DUF2345 was further validated and shown to be indispensable for the T6SS effector delivery and LysM was confirmed to assist the interaction between VgrG and the corresponding effector. Together, our results implied that these widely distributed domain families with similar genetic configurations may be required for the T6SS effector recruitment process.


  • Open Access

    A comprehensive dataset of animal-associated sarbecoviruses

    by Bo Liu, Peng Zhao, Panpan Xu, Yelin Han, Yuyang Wang, Lihong Chen, Zhiqiang Wu, Jian Yang

    Zoonotic spillover of sarbecoviruses (SarbeCoVs) from non-human animals to humans under natural conditions has led to two large-scale pandemics, the severe acute respiratory syndrome (SARS) pandemic in 2003 and the ongoing COVID-19 pandemic. Knowledge of the genetic diversity, geographical distribution, and host specificity of SarbeCoVs is therefore of interest for pandemic surveillance and origin tracing of SARS-CoV and SARS-CoV-2. This study presents a comprehensive repository of publicly available animal-associated SarbeCoVs, covering 1,535 viruses identified from 63 animal species distributed in 43 countries worldwide (as of February 14,2023). Relevant meta-information, such as host species, sampling time and location, was manually curated and included in the dataset to facilitate further research on the potential patterns of viral diversity and ecological characteristics. In addition, the dataset also provides well-annotated sequence sets of receptor-binding domains (RBDs) and receptor-binding motifs (RBMs) for the scientific community to highlight the potential determinants of successful cross-species transmission that could be aid in risk estimation and strategic design for future emerging infectious disease control and prevention.


  • Open Access

    Application of combined CRISPR screening for genetic and chemical-genetic interaction profiling in Mycobacterium tuberculosis

    by Mei-Yi Yan, Dandan Zheng, Si-Shang Li, Xin-Yuan Ding, Chun-Liang Wang, Xiao-Peng Guo, Lingjun Zhan, Qi Jin, Jian Yang, Yi-Cheng Sun

    CRISPR screening, including CRISPR interference (CRISPRi) and CRISPR-knockout (CRISPR-KO) screening, has become a powerful technology in the genetic screening of eukaryotes. In contrast with eukaryotes, CRISPR-KO screening has not yet been applied to functional genomics studies in bacteria. Here, we constructed genome-scale CRISPR-KO and also CRISPRi libraries in Mycobacterium tuberculosis (Mtb). We first examined these libraries to identify genes essential for Mtb viability. Subsequent screening identified dozens of genes associated with resistance/susceptibility to the antitubercular drug bedaquiline (BDQ). Genetic and chemical validation of the screening results suggested that it provided a valuable resource to investigate mechanisms of action underlying the effects of BDQ and to identify chemical-genetic synergies that can be used to optimize tuberculosis therapy. In summary, our results demonstrate the potential for efficient genome-wide CRISPR-KO screening in bacteria and establish a combined CRISPR screening approach for high-throughput investigation of genetic and chemical-genetic interactions in Mtb.


  • Top Cited Papers
    Open Access

    VFDB 2022: a general classification scheme for bacterial virulence factors

    by Bo Liu, Dandan Zheng, Siyu Zhou, Lihong Chen, Jian Yang

    The virulence factor database (VFDB, http://www.mgc.ac.cn/VFs/) is dedicated to presenting a comprehensive knowledge base and a versatile analysis platform for bacterial virulence factors (VFs). Recent developments in sequencing technologies have led to increasing demands to analyze potential VFs within microbiome data that always consist of many different bacteria. Nevertheless, the current classification of VFs from various pathogens is based on different schemes, which create a chaotic situation and form a barrier for the easy application of the VFDB dataset for future panbacterial metagenomic analyses. Therefore, based on extensive literature mining, we recently proposed a general category of bacterial VFs in the database and reorganized the VFDB dataset accordingly. Thus, all known bacterial VFs from 32 genera of common bacterial pathogens collected in the VFDB are well grouped into 14 basal categories along with over 100 subcategories in a hierarchical architecture. The new coherent and well-defined VFDB dataset will be feasible and applicable for future panbacterial analysis in terms of virulence factors. In addition, we introduced a redesigned JavaScript-independent web interface for the VFDB website to make the database readily accessible to all users with various client settings worldwide.